NOVONIX (NASDAQ:NVX) Stock, Quote.Headers.trade-ideas

Nuveen CA Dividend

Nuveen California Dividend Advantage Municipal Fund 2

AMEX

NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration and Mining, Battery Technology, and NOVONIX Anode Materials. Graphite Exploration and Mining segment is engaged in the exploration and development of high-grade flake graphite deposits. The NOVONIX Anode Materials segment develops and manufactures battery anode materials. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Technology segment generates maximum revenue for the company.

News

Penny Stocks

Markets

Tech

Trading Ideas

By M. Marin

EV + hybrids 12.7% of Ford&#39;s ‘24 vehicle sales to-date vs 8.3% in same period of ‘23… 

NVX: Positive Takeaways Recent EV Sales Trends

Small Cap

Intraday Update

Movers

ADIL

AEYE

Alterity Therapeutics Limited - American Depositary Shares

ATHE

BHVN

BTCY

CENX

CMAX

Envoy Medical, Inc. - Class A Common Stock

COCH

DXYZ

EGIO

EXTR

HUBC

IMCC

INFA

KAVL

KUKE

LGVN

LOCL

MNDR

MRNS

NMRA

NXPL

ONVO

PROK

PSNY

QTTB

RARE

RENT

SNGX

SNPO

SPCB

SPWR

SRFM

SWVL

TCON

VERU

VIAO

WIRE

Shares of  Ultragenyx Pharmaceutical Inc.  (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

APLD

DOGZ

FUFU

MNMD

MRNO

OFLX

RBLX

RVMD

TSHA

U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday.

Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday

NOVONIX Limited - American Depository Shares

NOVONIX Ltd

Under the agreement, NOVONIX will use its patented all-dry, zero-waste synthesis process to synthesize, test, and analyze cathode active materials (&quot;CAM&quot;) that will incorporate CBMM&#39;s suite of niobium products with the goal of developing a CAM with improved performance at a lower cost.

Reported Earlier, NOVONIX And CBMM Forge Joint Development Agreement Focused On Cathode Materials

WIIM

AILE

AKAM

ARLO

ASGN

AUUD

AXTI

BLZE

BNAI

CHKP

DAVE

DGLY

FFIV

GREE

GWRE

IDAI

INTA

IPGP

JAMF

LOGI

MITK

MOVE

MTLS

NICE

OBLG

OOMA

RGTI

SDIG

SGMA

SIMO

SOUN

SPSC

SYNA

WETH

Shares of stocks in the broader tech sector are trading lower amid a sell off due to US economy concerns.

Management

Reported Earlier, NOVONIX Names Robert Long As Chief Financial Officer, Effective September 1

NOVONIX Limited Announced It Has Been Granted A Patent For Its Proprietary All-dry, Zero-waste Cathode Synthesis Technology In Japan

General

CORRECTION: Novo Nordisk Ticker is "NVO"

<h3>Gainers</h3>
<ul>
<li>Spectaire Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPEC#NASDAQ">SPEC</a>) stock moved upwards by 148.9% to $0.85 during Friday's pre-market session. The company's market cap stands at $15.6 million. </li>
<li>Ascent Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) stock rose 35.31% to $0.15. The market value of their outstanding shares is at $13.2 million. </li>
<li>Sequans Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQNS#NYSE">SQNS</a>) shares moved upwards by 14.46% to $0.55. The company's market cap stands at $34.0 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>Minim (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MINM#NASDAQ">MINM</a>) shares increased by 10.13% to $3.15. The market value of their outstanding shares is at $8.8 million. </li>
<li>DatChat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DATS#NASDAQ">DATS</a>) shares rose 8.15% to $1.34. The market value of their outstanding shares is at $4.0 million. </li>
<li>NOVONIX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVX#NASDAQ">NVX</a>) stock moved upwards by 5.88% to $1.8. The company's market cap stands at $220.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Perfect (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PERF#NYSE">PERF</a>) stock decreased by 12.5% to $1.61 during Friday's pre-market session. The company's market cap stands at $163.9 million. </li>
<li>SMX (Security Matters) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) stock fell 12.38% to $0.14. The market value of their outstanding shares is at $5.5 million. </li>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) shares fell 11.35% to $0.35. The market value of their outstanding shares is at $34.3 million. </li>
<li>SmartKem (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTK#NASDAQ">SMTK</a>) stock declined by 8.19% to $5.91. The market value of their outstanding shares is at $10.1 million. </li>
<li>MMTEC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) shares declined by 6.95% to $0.35. The company's market cap stands at $69.6 million. </li>
<li>SPI Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPI#NASDAQ">SPI</a>) shares fell 6.49% to $0.43. The company's market cap stands at $13.5 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASTI

DATS

MINM

PERF

SMTK

SPEC

SQNS

12 Information Technology Stocks Moving In Friday's Pre-Market Session

By M. Marin
EV + hybrids 12.7% of Ford&#39;s &lsquo;24 vehicle sales to-date vs 8.3% in same period of &lsquo;23&hellip; 
We view strong 2024 electric vehicle (EV) sales as positive for Novonix (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvx#NASDAQ">NVX</a>). Last week, Ford Motor Company&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/f#NYSE">F</a>) provided statistics on vehicle sales to-date in 2024. Through the end of May, Ford had sold 37,208 EVs, up 87.8% year-over-year compared to 19,809 units during the same period of 2023. Sales of hybrid vehicles reached 74,049 units compared to 49,061 in 2023. That represents a 50.9% increase. EV sales are still relatively small as a percentage of total sales, but based on the 2024 data are gaining share versus traditional ICE (internal combustion engine) vehicles. For example, EVs have thus far represented 4.2% of Ford&#39;s total vehicle sales in 2024 compared to 2.4% during the same period of 2023. EV and hybrids combined represented 12.7% of Ford&#39;s total vehicle sales in 2024 compared to 8.3% during the same period of 2023.
<img src="//s27.q4cdn.com/906368049/files/pictures/2024/06112024_NVX_1.png" style="width:650px" />
Similarly, the CEO of General Motors Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gm#NYSE">GM</a>) indicated that May 2024 was its best month ever for EV sales in North America, according to Investor&#39;s Business Daily, despite recent fluctuations reflecting, among other factors, Bolt. In July 2021, GM recalled certain 2017&ndash;2019 models of its Chevrolet Bolt EV. GM continues to reaffirm its stated &quot;commitment to an all-electric future and meeting required fuel efficiency standards.&quot;
EVs and hybrids comprise a small but growing fraction of the total number of cars sold in the world. According to the International Energy Agency (IEA), EV &quot;sales neared 14 million in 2023. The share of electric cars in total sales has increased from around 4% in 2020 to 18% in 2018.&quot; According to IEA data, the U.S. generally ranks among the largest markets in terms of new EV sales per annum.
<img src="//s27.q4cdn.com/906368049/files/pictures/2024/06112024_NVX_2.png" style="width:650px" />
Numerous agreements to secure demand 
Reflecting rising consumer adoption of electric vehicles (EVs) and installations of electric storage systems (ESS), among other factors, demand for lithium-ion batteries is expected to grow significantly. To benefit from the anticipated surge in battery sales to power a variety of products, including EVs, consumer electronics and ESS, among others, Novonix&#39;s strategy is to become a tier-one global supplier in the rapidly growing advanced materials market and lithium-ion battery space.
NVX has signed numerous agreements to secure demand for its advanced materials. For example, NVX recently signed a binding off-take agreement to supply high-performance synthetic graphite anode material to Panasonic Energy&#39;s North American operations. The materials will come from Novonix&#39;s Riverside facility, which is located in Chattanooga, Tennessee. Panasonic Energy has agreed to purchase at least 10,000 tonnes of anode material over the 2025-2028 period for use in its U.S. plants, subject to Novonix achieving certain milestones regarding final mass production qualification timelines prior to 4Q25.
Another recent agreement is with PowerCo SE, which is part of the Volkswagen Group and was formed for Volkswagen to bundle its global battery activities into one key operating group. PowerCo oversees Volkswagen&#39;s global factory operations, cell technology developments and vertical integration. PowerCo has identified three gigafactory locations with aggregate capacity of up to 200 GWh per annum. One is located in Salzgitter, Germany, which is where PowerCo is based. The other two are in Valencia, Spain and St. Thomas, Canada. The two have signed a non-exclusive Testing and Development Agreement (TDA) to develop, test and analyze synthetic graphite anode materials customized to meet PowerCo&#39;s requirements. If the results are successful, the two might then enter into a supply agreement for developed products. NVX has entered into similar agreements with others that have led to supply deals.
In addition, Novonix expects to deliver anode material to Kore Power from the Riverside plant. Per the terms of an agreement with LG Energy Solution (LGES), LGES will have the option to purchase up to 50,000 tons of artificial graphite anode material over a 10-year period once mass production commences.&nbsp;We view these and other agreements as significant positives for NVX and believe agreements with leading participants related to the battery cell space underscore the benefits of and validate Novonix&#39;s strategy. We anticipate additional agreements in the near- to medium-term, as NVX continues its strategy to secure demand in advance of commercial production at the Riverside plant. Moreover, these agreements fulfill an important component of the company&#39;s 2024 four key objectives:
We view these and other agreements as significant positives for NVX and believe agreements with leading participants related to the battery cell space underscore the benefits of and validate Novonix&#39;s strategy. We anticipate additional agreements in the near- to medium-term, as NVX continues its strategy to secure demand in advance of commercial production at the Riverside plant. Moreover, these agreements fulfill an important component of the company&#39;s 2024 four key objectives:
&#9642; Pursue / maintain industry leading R&amp;D efforts for battery materials
&#9642; Scale operations &ndash; NVX believes it is on-track for timeline to deliver commercial production
&#9642; Secure new demand &ndash; NVX continues providing samples to major Tier 1 prospective customers
&#9642; Obtain additional financing &ndash; NVX has been awarded funds from DOE, industrial leader partners
NVX material shows ~30%-60% lower global warming potential&hellip;
NVX&#39;s &lsquo;cleaner&#39; materials compared to that of competitors reflects its lower carbon intensive production method, as well as its proximity to North American end markets. In testing its materials, the company has found that they are as or more effective compared to other products. In a study comparing its synthetic anode graphite material to that supplied from China, the leading source of the material, Novonix material demonstrated a roughly 30% to 60% decrease in GWP (global warming potential) when compared to synthetic graphite produced in two key regions in China that account for a combined 79% of global production of synthetic anode material, according to the study.
&hellip; and also outperforms for EV range, charge retention &hellip;
All in all, the company has tested its anode materials compared to industry leading materials including a Tesla Model S cell used as a reference benchmark and based on test results, the company believes that its anode material outperforms in direct head-to-head testing.
<img src="//s27.q4cdn.com/906368049/files/pictures/2024/06112024_NVX_3.png" style="width:650px" />
The proximity of NVX&#39;s Tennessee plant also means that the overall distribution carbon footprint is likely to be lower than for that of materials from overseas competitors. The current supply of critical battery materials is sourced primarily from China (see below). Moreover, sourcing critical battery materials primarily from China has other potential risks, in our opinion, including possible delivery disruption due to logistics challenges and due to geopolitical challenges, particularly given sometimes shifting trade relations between China and the U.S.
<img src="//s27.q4cdn.com/906368049/files/pictures/2024/06112024_NVX_4.png" style="width:650px" />
Tariffs, other risks related to sourcing material from China &hellip; 
Manufacturers in China produce about 65% of the world&#39;s graphite, according to the U.S. Geological Survey, and Chinese companies control an estimated 80+% of the market for automotive battery anodes. Moreover, sourcing critical battery materials primarily from China has potential risks, including geopolitical and economic. For example, tariffs and quotas can make materials supplied from China more costly and restrict the supply. Recently the U.S. Trade Representative (USTR) announced new, extended or higher tariffs from China effective June 15, 2024. NVX expects this will make its material more competitively priced. This is also likely to encourage continued development of a North American supply chain, in our view. NVX believes China&#39;s measures underscore the need for North American producers to develop a local supply chain for battery materials in the U.S.
Regulatory incentives in place to develop local battery space, supply chain&hellip; 
Conversely, the proximity of NVX&#39;s Tennessee plant is a competitive advantage compared to materials from China. Importantly, Novonix believes it has first mover advantage as an early manufacturer of synthetic graphite in North America. It also expects to benefit from regulatory incentives to develop clean energy sources. recent regulatory indications are favorable for NVX; synthetic graphite is eligible for rebates under government programs.
The Inflation Reduction Act (IRA) provides economic incentives to companies that are developing a local supply chain for batteries and battery materials. These benefits support the production of critical minerals and battery materials such as synthetic graphite, for which Novonix will be eligible, and for local manufacturing of battery cells and Panasonic Energy&#39;s North American plants will qualify.

Trading Halt: Halt status updated at 7:00:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halted at 3:58:13 a.m. ET - Trading Halt: Halt News Pending

Chardan Capital analyst Brian Dobson initiates coverage on NOVONIX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVX#NASDAQ">NVX</a>) with a Buy rating and announces Price Target of $4.

Price Target

Initiation

Analyst Ratings

Chardan Capital Initiates Coverage On NOVONIX with Buy Rating, Announces Price Target of $4

Reported Earlier, NOVONIX CFO Nick Liveris To Retire And Transition To Non-Executive Director Role

As previously announced, NOVONIX has agreed to divest MD South Tenements Pty Ltd, its wholly owned subsidiary that holds the Mount Dromedary natural graphite exploration interests, to Axon Graphite Limited, a subsidiary of LEL. LEL will contribute its interest in its Burke and Corella graphite projects to Axon pursuant to the agreement

Reported Earlier, NOVONIX Completes Due Diligence For Natural Graphite Merger With Axon Graphite

Reported Earlier, PowerCo Partners With NOVONIX For Development And Testing Of Synthetic Graphite Anodes

<h3>Gainers</h3>
<ul>
<li>AppLovin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) shares moved upwards by 15.1% to $85.18 during Thursday's pre-market session. The company's market cap stands at $28.0 billion. The company's, Q1 earnings came out yesterday. </li>
<li>NOVONIX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVX#NASDAQ">NVX</a>) shares moved upwards by 11.94% to $2.53. The company's market cap stands at $309.2 million. </li>
<li>Pagaya Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGY#NASDAQ">PGY</a>) stock rose 10.43% to $11.6. The company's market cap stands at $817.2 million. As per the press release, Q1 earnings came out today. </li>
<li>XIAO-I (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIXI#NASDAQ">AIXI</a>) stock rose 10.31% to $1.39. The company's market cap stands at $100.1 million. </li>
<li>HubSpot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) stock rose 8.8% to $642.0. The company's market cap stands at $32.6 billion. The company's, Q1 earnings came out yesterday. </li>
<li>CISO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISO#NASDAQ">CISO</a>) shares moved upwards by 8.5% to $1.0. The market value of their outstanding shares is at $12.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>EMCORE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMKR#NASDAQ">EMKR</a>) shares declined by 38.6% to $1.78 during Thursday's pre-market session. The company's market cap stands at $13.7 million. As per the press release, Q2 earnings came out yesterday. </li>
<li>Cerence (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNC#NASDAQ">CRNC</a>) shares decreased by 16.58% to $7.98. The market value of their outstanding shares is at $332.3 million. As per the news, the Q2 earnings report came out today. </li>
<li>EPAM Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAM#NYSE">EPAM</a>) stock fell 14.15% to $213.95. The market value of their outstanding shares is at $12.3 billion. As per the press release, Q1 earnings came out today. </li>
<li>X3 Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTKG#NASDAQ">XTKG</a>) stock decreased by 11.69% to $0.73. The market value of their outstanding shares is at $200.0 million. </li>
<li>Allegro Microsystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) shares fell 10.43% to $26.3. The company's market cap stands at $5.0 billion. As per the press release, Q4 earnings came out today. </li>
<li>PAR Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAR#NYSE">PAR</a>) shares fell 10.01% to $40.29. The company's market cap stands at $1.3 billion. As per the press release, Q1 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIXI

ALGM

CISO

CRNC

EMKR

EPAM

HUBS

XTKG

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rare#NASDAQ">RARE</a>) fell sharply during Monday&rsquo;s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) shares surged 71.5% to $0.6679 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA.</li>
<li>Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) surged 54% to $2.6350 following insider buys from multiple company executives.</li>
<li>SuperCom Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spcb#NASDAQ">SPCB</a>) shares gained 39.4% to $0.3849 after jumping around 18% on Friday.</li>
<li>Piedmont Lithium Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pll#NYSE">PLL</a>) shares gained 32.1% to $16.75 following a 5% decline on Friday.</li>
<li>Snap One Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpo#NASDAQ">SNPO</a>) surged 31.6% to $10.71 after the company announced that it will be acquired by Resideo Technologies.</li>
<li>Organovo Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onvo#NASDAQ">ONVO</a>) shares surged 30.9% to $1.32 after the company announced Phase 2 results for FXR314. Study results demonstrated statistically significant reduction in liver fat content from baseline in patients receiving FXR314 compared to placebo.</li>
<li>Kuke Music Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kuke#NASDAQ">KUKE</a>) jumped 27% to $2.7650.</li>
<li>HUB Cyber Security Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hubc#NASDAQ">HUBC</a>) gained 24% to $1.61 after gaining over 11% on Friday.</li>
<li>Edgio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egio#NASDAQ">EGIO</a>) gained 24% to $22.18.</li>
<li>Kaival Brands Innovations Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kavl#NASDAQ">KAVL</a>) surged 23.6% to $3.30.</li>
<li>Envoy Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coch#NASDAQ">COCH</a>) gained 22.6% to $6.19.</li>
<li>Medical Properties Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mpw#NYSE">MPW</a>) rose 19.9% to $4.7850 after the company announced that it sold its majority interest in Utah Hospitals.</li>
<li>CareMax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmax#NASDAQ">CMAX</a>) climbed 19.5% to $3.78.</li>
<li>SES AI Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ses#NYSE">SES</a>) surged 18.7% to $1.77.</li>
<li>Mobile-health Network Solutions (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mndr#NASDAQ">MNDR</a>) gained 17.7% to $17.67.</li>
<li>Adial Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adil#NASDAQ">ADIL</a>) rose 16.7% to $2.72.</li>
<li>ProKidney Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prok#NASDAQ">PROK</a>) gained 16.7% to $2.0426.</li>
<li>Biotricity, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btcy#NASDAQ">BTCY</a>) rose 16.5% to $1.34.</li>
<li>Yatsen Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ysg#NYSE">YSG</a>) gained 13.3% to $3.41.</li>
<li>Destiny Tech100 Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NASDAQ">DXYZ</a>) shares gained 12.8% to $32.71 after dipping 42% on Friday.</li>
<li>Encore Wire Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wire#NASDAQ">WIRE</a>) surged 11.7% to $291.60 after the company entered an agreement to be acquired by Prysmian for $290 per share in cash.</li>
<li>Century Aluminum Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cenx#NASDAQ">CENX</a>) gained 9.5% to $18.05.</li>
<li>Extreme Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/extr#NASDAQ">EXTR</a>) gained 5.7% to $11.31. B. Riley Securities analyst Dave Kang upgraded Extreme Networks from Neutral to Buy and maintained a $14 price target.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Marinus Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrns#NASDAQ">MRNS</a>) shares dipped 77% to $1.6800 after the company provided an update on the Phase 3 RAISE trial and reported preliminary Q1 financial results.</li>
<li>Swvl Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swvl#NASDAQ">SWVL</a>) fell 35% to $8.58.</li>
<li>VIA optronics AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/viao#NASDAQ">VIAO</a>) dipped 34% to $0.2765.</li>
<li>Veru Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/veru#NASDAQ">VERU</a>) fell 24% to $1.1550. Oppenheimer analyst Leland Gershell reiterated Veru with an Outperform and lowered the price target from $7 to $5.</li>
<li>Rent the Runway, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rent#NASDAQ">RENT</a>) dipped 19.8% to $15.42.</li>
<li>NextPlat Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxpl#NASDAQ">NXPL</a>) fell 19.8% to $1.50 after jumping 24% on Friday. The company entered into a definitive business combination agreement with its majority-owned subsidiary Progressive Care Inc.</li>
<li>Cyngn Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyn#NASDAQ">CYN</a>) shares fell 19.1% to $0.1170 after declining around 7% on Friday.</li>
<li>ProMIS Neurosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmn#NASDAQ">PMN</a>) fell 15.6% to $1.95.</li>
<li>Biohaven Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhvn#NASDAQ">BHVN</a>) dipped 15.4% to $44.90. Biohaven showcased innovative neuroscience portfolio with 20 presentations at the 2024 AAN Annual Meeting.</li>
<li>Neumora Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmra#NASDAQ">NMRA</a>) shares declined 15.1% to $11.48 after the FDA placed a clinical hold on the company&#39;s Phase 1 NMRA-266 study.</li>
<li>Alterity Therapeutics Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/athe#NASDAQ">ATHE</a>) dipped 15% to $2.49.</li>
<li>Surf Air Mobility Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srfm#NASDAQ">SRFM</a>) fell 15% to $0.53.</li>
<li>IM Cannabis Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imcc#NASDAQ">IMCC</a>) fell 14.2% to $0.5399.</li>
<li>Polestar Automotive Holding Uk Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psny#NASDAQ">PSNY</a>) fell 12.7% to $1.2699. On Friday, Cantor Fitzgerald analyst Andres Sheppard reiterated Polestar Automotive with an Overweight and maintained a $5 price target.</li>
<li>Desktop Metal, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dm#NYSE">DM</a>) fell 10.8% to $0.8510.</li>
<li>Local Bounti Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/locl#NYSE">LOCL</a>) declined 10.2% to $2.1550.</li>
<li>Q32 Bio Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qttb#NASDAQ">QTTB</a>) fell 10% to $26.00.</li>
<li>SunPower Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwr#NASDAQ">SPWR</a>) fell 8.3% to $2.2750.</li>
<li>Informatica Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/infa#NASDAQ">INFA</a>) dipped 8.1% to $35.36 amid increased volatility following reports suggesting Salesforce is in talks to buy the company.</li>
<li>TRACON Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcon#NASDAQ">TCON</a>) declined 8.1% to $2.1699 after falling around 9% on Friday.</li>
<li>NOVONIX Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nvx#NYSE">NVX</a>) declined 7.2% to $2.63.</li>
<li>AudioEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aeye#NASDAQ">AEYE</a>) fell 6.6% to $12.86 after declining around 7% on Friday.</li>
<li>OncoCyte Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocx#NASDAQ">OCX</a>) fell 6.6% to $2.5301. Oncocyte announced a transplant assay partnership agreement with Bio-Rad laboratories.</li>
<li>BlackBerry Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bb#NYSE">BB</a>) fell 6.1% to $2.8650.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38249138/dow-jumps-over-300-points-goldman-sachs-posts-upbeat-earnings"> Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings</a>

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

CMTL

CSPI

HKIT

KEYS

OMQS

OPRA

OUST

PSTG

QIWI

QMCO

SVRE

VSAT

WAVD

ZBRA

Shares of companies within the broader tech sector are trading lower amid overall market weakness on rate cut uncertainty.

U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday.
Shares of Roblox Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rblx#NYSE">RBLX</a>) rose during Wednesday&rsquo;s session following reports the company has ramped up efforts to attract advertisers to its platform and made other moves to <a href="https://www.benzinga.com/news/24/04/38182117/whats-going-on-with-roblox-stock-wednesday">boost advertising sales</a>.
Roblox shares gained 2.6% to $40.10 on Wednesday.
Here are some other big stocks recording gains&nbsp;in today&rsquo;s session.
<ul>
<li>Dogness (International) Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dogz#NASDAQ">DOGZ</a>) shares jumped 22.9% to $8.48.</li>
<li>Murano Global Investments Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrno#NASDAQ">MRNO</a>) gained 13.6% to $11.70.</li>
<li>Aurora Cannabis Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acb#NASDAQ">ACB</a>) rose 11.8% to $7.11. International Star Inc. appointed Todd Masse as new CEO.</li>
<li>Taysha Gene Therapies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsha#NASDAQ">TSHA</a>) jumped 10.1% to $3.26. Piper Sandler recently initiated coverage on the stock with an Overweight rating and a price target of $9.</li>
<li>Revolution Medicines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvmd#NASDAQ">RVMD</a>) gained 8.4% to $35.76.</li>
<li>Mind Medicine (MindMed) Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnmd#NASDAQ">MNMD</a>) jumped 7.7% to $10.82.</li>
<li>Applied Digital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apld#NASDAQ">APLD</a>) shares rose 6.4% to $3.0350. Applied Digital has moved its fiscal third quarter 2024 earnings conference call to April 11, 2024, at 5:00 p.m. ET.</li>
<li>Omega Flex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oflx#NASDAQ">OFLX</a>) gained 6.2% to $75.14.</li>
<li>NOVONIX Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvx#NASDAQ">NVX</a>) surged 6% to $2.8189.</li>
<li>ICZOOM Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/izm#NASDAQ">IZM</a>) rose 5.7% to $35.20.</li>
<li>BitFuFu Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fufu#NASDAQ">FUFU</a>) gained 4.7% to $4.18. BitFuFu is expected to release its financial results for the full year ended Dec. 31, 2023, on April 11, 2024 before the opening bell.</li>
<li>TAL Education Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tal#NYSE">TAL</a>) rose 4.6% to $11.93. TAL Education Group is expected to release its unaudited financial results for the fourth quarter and fiscal year 2024 ended Feb. 29, 2024 on April 25, 2024.</li>
<li>GrafTech International Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eaf#NYSE">EAF</a>) jumped 3.7% to $1.68.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38176517/how-to-earn-500-a-month-from-citigroup-stock-ahead-of-q1-earnings-report"> How To Earn $500 A Month From Citigroup Stock Ahead Of Q1 Earnings Report</a>

<h3>Gainers</h3>
<ul>
<li>Marin Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares increased by 85.7% to $0.53 during Wednesday's pre-market session. The company's market cap stands at $9.6 million. </li>
<li>Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) stock rose 49.32% to $2.21. The company's market cap stands at $155.8 million. </li>
<li>Presto Automation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRST#NASDAQ">PRST</a>) stock moved upwards by 16.66% to $0.21. The market value of their outstanding shares is at $21.8 million. </li>
<li>Mawson Infra Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIGI#NASDAQ">MIGI</a>) shares moved upwards by 12.82% to $1.32. The company's market cap stands at $21.9 million. </li>
<li>NOVONIX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVX#NASDAQ">NVX</a>) shares rose 12.78% to $3.0. The market value of their outstanding shares is at $366.5 million. </li>
<li>OMNIQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMQS#NASDAQ">OMQS</a>) shares rose 12.11% to $0.36. The company's market cap stands at $3.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ascent Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) shares decreased by 50.6% to $0.14 during Wednesday's pre-market session. </li>
<li>VIA optronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIAO#NYSE">VIAO</a>) stock declined by 33.17% to $0.6. The market value of their outstanding shares is at $13.6 million. </li>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) shares decreased by 10.25% to $0.27. The market value of their outstanding shares is at $3.6 million. </li>
<li>Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) shares fell 9.0% to $10.72. The company's market cap stands at $309.2 million. The company's, Q3 earnings came out yesterday. </li>
<li>SoundHound AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) shares decreased by 8.25% to $4.45. The market value of their outstanding shares is at $1.3 billion. </li>
<li>Semantix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STIX#NASDAQ">STIX</a>) shares fell 7.66% to $0.37. The market value of their outstanding shares is at $28.9 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEHR

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MRIN

PRST

STIX

12 Information Technology Stocks Moving In Wednesday's Pre-Market Session

Shares of STAAR Surgical Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/staa#NASDAQ">STAA</a>) rose sharply during Thursday&rsquo;s session after the company issued strong preliminary first-quarter net sales guidance.
STAAR Surgical shares jumped 13.3% to $44.30 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) shares climbed 130.1% to $2.9790. TCBP announced execution of non-binding letter of intent for acquisition of NK Platform Technologies.</li>
<li>Allurion Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alur#NASDAQ">ALUR</a>) gained 70% to $2.8801 after the company announced the commercial availability of its Virtual Care Suite in the United States. Also, Chardan Capital initiated coverage on the stock with a Buy rating and announced a $5 price target.</li>
<li>Tevogen Bio Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tvgn#NASDAQ">TVGN</a>) shares climbed 40.6% to $3.58. Tevogen Bio, on Wednesday, appointed Tapan V Shah as Head of Investor Relations and Corporate Development.</li>
<li>HWH International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hwh#NASDAQ">HWH</a>) gained 38.8% to $2.1765.</li>
<li>Candel Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cadl#NASDAQ">CADL</a>) rose 36.3% to $2.2899 after the company announced interim data from the randomized phase 2 clinical trial of CAN-2409 in non-metastatic prostate cancer.</li>
<li>MacroGenics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgnx#NASDAQ">MGNX</a>) climbed 27.8% to $17.47. MacroGenics announced TAMARACK study data will not be presented at the ASCO Annual Meeting.</li>
<li>E-Home Household Service Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ejh#NASDAQ">EJH</a>) gained 27% to $2.22.</li>
<li>Reliance Global Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reli#NASDAQ">RELI</a>) gained 24.6% to $0.46 after the company reported FY23 earnings.</li>
<li>Simulations Plus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slp#NASDAQ">SLP</a>) rose 22.5% to $47.12 after the company posted better-than-expected results for its second quarter.</li>
<li>Vast Renewables Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vste#NASDAQ">VSTE</a>) gained 22.3% to $8.81.</li>
<li>Sportsman&#39;s Warehouse Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwh#NASDAQ">SPWH</a>) gained 21.3% to $3.7950 following a narrower-than-expected quarterly loss.</li>
<li>Gorilla Technology Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grrr#NASDAQ">GRRR</a>) jumped 19% to $0.8729 after the company reported a year-over-year increase in FY23 sales results.</li>
<li>Levi Strauss &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/levi#NYSE">LEVI</a>) shares rose 18.3% to $22.10 after the company reported upbeat earnings for its first quarter and boosted its 2024 earnings guidance.</li>
<li>NOVONIX Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nvx#NYSE">NVX</a>) gained 15.4% to $2.83.</li>
<li>Zeta Global Holdings Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zeta#NYSE">ZETA</a>) climbed 14.8% to $12.09 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $12 to $17.</li>
<li>Graphjet Technology (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gti#NASDAQ">GTI</a>) gained 13.3% to $8.17</li>
<li>MaxLinear, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mxl#NASDAQ">MXL</a>) gained 11.8% to $24.22. MaxLinear is expected to release its financial results for the first quarter 2024 after the closing bell on April 24, 2024.</li>
<li>Eiger BioPharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eigr#NASDAQ">EIGR</a>) gained 9.7% to $1.81. Eiger Biopharmaceuticals said on April 2, it received a notice from the Nasdaq that the company&rsquo;s common stock will be delisted from Nasdaq.</li>
<li>Destiny Tech100 Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NASDAQ">DXYZ</a>) shares gained 8.8% to $29.39 after jumping 27% on Wednesday.</li>
<li>Addex Therapeutics Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adxn#NASDAQ">ADXN</a>) shares rose 8.2% to $16.76. Addex Therapeutics shares gained 18% on Wednesday after the company and funds affiliated with Perceptive Advisors announced the launch of Neurosterix..</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) gained 7.4% to $1,724.42 amid a rise in Bitcoin.</li>
<li>Enphase Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/enph#NASDAQ">ENPH</a>) climbed 7% to $126.86.</li>
<li>HubSpot, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hubs#NYSE">HUBS</a>) gained 6% to $664.51 following a report suggesting Alphabet is in talks with advisors about a potential offer for the company.</li>
<li>BlackBerry Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bb#NYSE">BB</a>) climbed 4% to $2.9223 after the company reported fourth-quarter results and issued FY25 guidance.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>eFFECTOR Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eftr#NASDAQ">EFTR</a>) shares dipped 80.7% to $3.1801. The company announced topline results from the primary analysis of the randomized Phase 2 KICKSTART trial of tomivosertib combined with pembrolizumab in non-small cell lung cancer.</li>
<li>Keyarch Acquisition Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kych#NASDAQ">KYCH</a>) fell 34.5% to $5.94.</li>
<li>View, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/view#NASDAQ">VIEW</a>) fell 29.4% to $0.3601. View shares fell on Wednesday after the company filed for Chapter 11 bankruptcy.</li>
<li>Achilles Therapeutics plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/achl#NASDAQ">ACHL</a>) declined 27% to $0.88 after the company reported fourth-quarter financial results. The company announced interim Phase I/IIa data on the use of clonal neoantigen reactive T cells from the CHIRON study in advanced unresectable or metastatic non-small cell lung cancer and the THETIS study in recurrent or metastatic malignant melanoma.</li>
<li>KWESST Micro Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kwe#NASDAQ">KWE</a>) fell 24.4% to $0.85 after the company announced a proposed US public offering.</li>
<li>AXT, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axti#NASDAQ">AXTI</a>) fell 22.2% to $3.85. Traders circulated J Capital short report.</li>
<li>XTI Aerospace, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xtia#NASDAQ">XTIA</a>) fell 20.9% to $3.64 after gaining 31% on Wednesday.</li>
<li>DigiAsia Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/faas#NASDAQ">FAAS</a>) fell 20% to $5.37.</li>
<li>Lamb Weston Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lw#NYSE">LW</a>) declined 17.5% to $83.40 after the company reported weak third-quarter results and cut its FY24 outlook.</li>
<li>Selina Hospitality PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slna#NASDAQ">SLNA</a>) dipped 17.5% to $0.0811.</li>
<li>Casa Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/casa#NASDAQ">CASA</a>) declined 16.3% to $0.0460. Casa Systems said the company and some units entered into asset purchase agreement with Lumine providing for sale and purchase of debtors&#39; Cloud/Ran APA assets.</li>
<li>Kintara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktra#NASDAQ">KTRA</a>) fell 15.2% to $0.1390. Kintara Therapeutics recently entered a merger agreement with TuHURA Biosciences.</li>
<li>Flora Growth Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flgc#NASDAQ">FLGC</a>) fell 13.5% to $2.3095 after the company reported the launch of proposed underwritten public offering of common shares.</li>
<li>GCT Semiconductor Holding, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gcts#NYSE">GCTS</a>) fell 13.1% to $5.96.</li>
<li>SolarMax Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smxt#NASDAQ">SMXT</a>) dipped 10.9% to $11.75.</li>
<li>LAMF Global Ventures Corp. I (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvc#NASDAQ">LGVC</a>) shares tumbled 10.2% to $9.97. LAMF Global Ventures Corp. I shares gained 3% on Wednesday after the company announced shareholders approved the previously announced business combination with Nuvo.</li>
<li>ARCA biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abio#NASDAQ">ABIO</a>) fell 8.9% to $2.96. ARCA Biopharma shares jumped 90% on Wednesday after the company and Oruka Therapeutics announced a merger agreement.</li>
<li>Aquestive Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aqst#NASDAQ">AQST</a>) fell 8.9% to $3.9850 after the company filed for an up to $250 million mixed shelf offering.</li>
<li>OneMedNet Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onmd#NASDAQ">ONMD</a>) shares fell 8.6% to $0.97. OneMedNet shares jumped 34% on Wednesday after the company completed a securities purchase agreement to provide up to $4.54 million in funding.</li>
<li>Rent the Runway, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rent#NASDAQ">RENT</a>) fell 8.6% to $5.37.</li>
<li>Paramount Global (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/para#NASDAQ">PARA</a>) fell 8.2% to $12.40 following a report suggesting the Ellison-led bid would require the company to raise new equity.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38092036/bitcoin-tops-66-000-following-jobless-claims-data-ethena-emerges-as-top-gainer"> Bitcoin Tops $66,000 Following Jobless Claims Data; Ethena Emerges As Top Gainer</a>

ABIO

ACHL

ADXN

ALUR

AQST

CADL

CASA

EFTR

EIGR

ENPH

FAAS

FLGC

GCTS

GRRR

Kintara Therapeutics, Inc. - Common Stock

KTRA

KYCH

LEVI

LGVC

MGNX

MSTR

ONMD

PARA

RELI

SLNA

SMXT

SPWH

STAA

TCBP

TVGN

VIEW

Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

NOVONIX

NOVONIX (NVX) Forecast

NOVONIX (NASDAQ:NVX) Stock, Quote.Headers.trade-ideas